2009Psychiatry ResearchRequires access

Effectiveness of a quantitative electroencephalographic biomarker for predicting differential response or remission with escitalopram and bupropion in major depressive disorder

Andrew F. Leuchter, Ian A. Cook, William S. Gilmer, Lauren B. Marangell, Karl Burgoyne, Robert H. Howland, Madhukar H. Trivedi, Sidney Zisook, Rakesh K. Jain, Maurizio Fava, Dan V. Iosifescu, Scott Greenwald

Open publisher page 121 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 121 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Escitalopram, Bupropion, Major depressive disorder, Antidepressant, Citalopram, Psychology, Internal medicine, Medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Effectiveness of a quantitative electroencephalographic biomarker for predicting differential response or remission with escitalopram and bupropion in major depressive disorder — Research Paper | ScholarLens